Clinical trialNCT00270894CompletedPhase 2Interventional

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

SponsorAccelerated Community Oncology Research NetworkEnrollment30Breast Neoplasm

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lee S Schwartzberg, MD, FACP
Accelerated Community Oncology Research Network, Inc. (ACORN)
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Advanced Medical Specialties
Miami, Florida, United States
Augusta Oncology Associates
Augusta, Georgia, United States
Cental Georgia Cancer Care
Macon, Georgia, United States
Northwest Georgia Oncology Centers, Pc
Marietta, Georgia, United States
Hematology Oncology Centers of the Northern Rockies, Pc
Billings, Montana, United States
Arena Oncology Associates
Great Neck, New York, United States
the West Clinic
Memphis, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2005
Primary completion: 31 Aug 2011
Completion: 31 Aug 2011
Last update posted: 20 Mar 2012
Registered enrollment: 30
Registry id: NCT00270894

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.